| __timestamp | Dr. Reddy's Laboratories Limited | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 7751000 |
| Thursday, January 1, 2015 | 42585000000 | 10251000 |
| Friday, January 1, 2016 | 45702000000 | 9575000 |
| Sunday, January 1, 2017 | 46372000000 | 10912000 |
| Monday, January 1, 2018 | 46910000000 | 11049000 |
| Tuesday, January 1, 2019 | 48890000000 | 11646000 |
| Wednesday, January 1, 2020 | 50129000000 | 13265000 |
| Friday, January 1, 2021 | 54559000000 | 25805000 |
| Saturday, January 1, 2022 | 62081000000 | 35182000 |
| Sunday, January 1, 2023 | 105931000000 | 94999000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Dr. Reddy's Laboratories Limited and Viridian Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, Dr. Reddy's has seen its SG&A expenses grow by approximately 173%, peaking in 2023. This increase reflects their expansive global operations and strategic investments. In contrast, Viridian Therapeutics, a smaller player, has maintained a more modest SG&A growth, with expenses increasing by about 1,125% over the same period, albeit from a much smaller base. This rapid rise highlights Viridian's aggressive scaling efforts. While Dr. Reddy's manages larger absolute costs, Viridian's relative growth underscores its dynamic expansion strategy. The data from 2024 is incomplete, leaving room for speculation on future trends. Understanding these dynamics is key for investors and industry analysts alike.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Exelixis, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Galapagos NV
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Ascendis Pharma A/S vs Viridian Therapeutics, Inc.: SG&A Expense Trends
Pharming Group N.V. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Viking Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Galapagos NV vs Viridian Therapeutics, Inc.